HEXABRIX Side Effects

6946874-1 | Blood Pressure Decreased, Bradycardia, Cold Sweat, Feeling Cold, Nausea
on Jun 09, 2010 Male patient from JAPAN , weighting 63.00 lb, was diagnosed with angiogram cerebral and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, bradycardia, cold sweat, feeling cold, nausea (What is nausea?). Hexabrix dosage: Dosage: 20, Ml Millilitre(s), 1, 1, Days Intra-arterial. During the same period patient was treated with CARBOCAIN: SUBCUTANEOUS / MEPIVACAINE HYDROCHLORIDE (View Carbocain: Subcutaneous / Mepivacaine Hydrochloride Review and Carbocain: Subcutaneous / Mepivacaine Hydrochloride Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6841762-3 | Anaemia, Cheilitis, Dry Eye, Erythema Multiforme, Hypersensitivity, Lip Pain, Lymphopenia, Mouth Ulceration, Mucosal Erosion
Patient was taking Hexabrix (View Usage). Patient had the following side effects: anaemia, cheilitis, dry eye, erythema multiforme, hypersensitivity, lip pain, lymphopenia, mouth ulceration, mucosal erosion on Jun 10, 2010 from FRANCE Additional patient health information: Female patient , 72 years of age, was diagnosed with fistulogram and. Hexabrix dosage: 100 Ml Millilitre(s), 1, 1, Total, Intravenous. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVOTHYROX / LEVOTHYROXINE (View Levothyrox / Levothyroxine Review and Levothyrox / Levothyroxine Label ), MIMPARA / CINACALCET (View Mimpara / Cinacalcet Review and Mimpara / Cinacalcet Label ), FOSRENOL / LANTHENE (View Fosrenol / Lanthene Review and Fosrenol / Lanthene Label ), KAYEXALATE / POLYSTYRENE SODIUM (View Kayexalate / Polystyrene Sodium Review and Kayexalate / Polystyrene Sodium Label ), OROCAL / CALCIUM CARBONATE (View Orocal / Calcium Carbonate Review and Orocal / Calcium Carbonate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6776571-7 | Anaemia, Erythema Multiforme, Eye Pain, Lymphopenia, Proctalgia, Renal Failure Chronic
Adverse event was reported on Jun 10, 2010 by a Female patient taking Hexabrix (View Usage) (Dosage: 100, Ml Millilitre(s), 1, 1,intravenous (not Otherwise Specified)) was diagnosed with fistulogram and. Location: FRANCE , 72 years of age, After Hexabrix was administered, patient had the following side effects: anaemia, erythema multiforme, eye pain, lymphopenia, proctalgia, renal failure chronic. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVOTHYROX / LEVOTHYROXINE (View Levothyrox / Levothyroxine Review and Levothyrox / Levothyroxine Label ), MIMPARA / CINACALCET (View Mimpara / Cinacalcet Review and Mimpara / Cinacalcet Label ), FOSRENOL / LANTHANE (View Fosrenol / Lanthane Review and Fosrenol / Lanthane Label ), KAYEXALATE / POLYSTYRENE SODIUM SULPHONATE (View Kayexalate / Polystyrene Sodium Sulphonate Review and Kayexalate / Polystyrene Sodium Sulphonate Label ), OROCAL / CALCIUM CARBONATE (View Orocal / Calcium Carbonate Review and Orocal / Calcium Carbonate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6697817-X | Cough, Dysphonia, Pruritus
on Apr 13, 2010 Male patient from SPAIN , 67 years of age, was diagnosed with arteriogram coronary and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dysphonia, pruritus. Hexabrix dosage: .


6687410-7 | Electrocardiogram St Segment Elevation, Hypersensitivity, Hypotension
on Apr 02, 2010 Male patient from FRANCE , 51 years of age, was diagnosed with arteriogram coronary and was treated with Hexabrix (View Usage). Patient had the following side effects: electrocardiogram st segment elevation, hypersensitivity, hypotension. Hexabrix dosage: 20, Ml Millilitre(s), 1, 1, Total Intra-arterial. Patient was hospitalized.

6687408-9 | Hypersensitivity
Patient was taking Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: hypersensitivity on Apr 12, 2010 from FRANCE Additional patient health information: Male patient , 52 years of age, was diagnosed with arteriogram coronary and. Hexabrix dosage: 20, Ml Millilitre(s), 1, 1, Total Intra-arterial. Patient was hospitalized.

6672030-0 | Face Oedema, Hypotension, Hypoxia, Latex Allergy, Rash Maculo-papular, Respiratory Depression, Use Of Accessory Respiratory Muscles
Adverse event was reported on Mar 17, 2010 by a Female patient taking Hexabrix (View Usage) (Dosage: ) was diagnosed with cardiovascular evaluation and. Location: JAPAN , child 2 years of age, Patient experienced the following unwanted or unexpected effects: face oedema, hypotension, hypoxia, latex allergy (What is latex allergy?), rash maculo-papular, respiratory depression, use of accessory respiratory muscles.

6668577-3 | Face Oedema, Hypoxia, Rash, Use Of Accessory Respiratory Muscles
on Mar 17, 2010 Female patient from JAPAN , child 2 years of age, was treated with Hexabrix (View Usage). Patient had the following side effects: face oedema, hypoxia, rash (What is rash?), use of accessory respiratory muscles. Hexabrix dosage: .

6664671-1 | Bradycardia, Bronchospasm, Face Oedema, Hypotension
on Dec 03, 2007 Male patient from FRANCE , 61 years of age, weighting 209.4 lb, was diagnosed with angiogram and was treated with Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: bradycardia, bronchospasm, face oedema, hypotension. Hexabrix dosage: 50, Ml Millilitre(s), 1, 1,total Intra-arterial.

6664669-3 | Off Label Use, Status Epilepticus
Patient was taking Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, status epilepticus on Jul 20, 2007 from FRANCE Additional patient health information: Male patient , 48 years of age, was diagnosed with spinal myelogram and. Hexabrix dosage: Intrathecal.

6664668-1 | Myoclonus, Neurological Decompensation, Off Label Use, Paraesthesia, Pruritus, Sensation Of Heaviness
Adverse event was reported on Feb 25, 2009 by a Male patient taking Hexabrix (View Usage) (Dosage: 12, Ml Millilitre(s), 1, 1,total Intrathecal) was diagnosed with spinal myelogram and. Location: FRANCE , 65 years of age, weighting 198.4 lb, Patient had the following side effects: myoclonus, neurological decompensation, off label use, paraesthesia, pruritus, sensation of heaviness. Patient was hospitalized and became disabled.

6664667-X | Anaphylactic Shock
on Sep 07, 2009 Male patient from FRANCE , 39 years of age, was diagnosed with arteriogram coronary and was treated with Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: anaphylactic shock. Hexabrix dosage: . During the same period patient was treated with SECTRAL (View Sectral Review and Sectral Label ), PROCORALAN: / IVABRADINE (View Procoralan: / Ivabradine Review and Procoralan: / Ivabradine Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ), OMACOR: / DOCOSAHEXAENOIC ACID EICOSAPENTAENOIC ACID A TOCOPHEROL (View Omacor: / Docosahexaenoic Acid - Eicosapentaenoic Acid - A-tocopherol Review and Omacor: / Docosahexaenoic Acid - Eicosapentaenoic Acid - A-tocopherol Label ), KARDEGIC: / LYSINE ACETYLSALICYLATE (View Kardegic: / Lysine Acetylsalicylate Review and Kardegic: / Lysine Acetylsalicylate Label ), PLAVIX (View Plavix Review and Plavix Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

6656329-X | Anaphylactic Shock, Chest Pain
on Feb 08, 2010 Male patient from JAPAN , 57 years of age, weighting 152.1 lb, was diagnosed with angiogram and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, chest pain (What is chest pain?). Hexabrix dosage: 10, Ml Millilitre(s), 1, 1, Total; Intra-arterial. During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), ATARAX (View Atarax Review and Atarax Label ), KYTRIL (View Kytril Review and Kytril Label ).

6656306-9 | Face Oedema, Hypoxia, Rash, Use Of Accessory Respiratory Muscles
Patient was taking Hexabrix (View Usage). Patient had the following side effects: face oedema, hypoxia, rash (What is rash?), use of accessory respiratory muscles on Mar 17, 2010 from JAPAN Additional patient health information: Female patient , child 2 years of age, . Hexabrix dosage: .

6644171-5 | Anaphylactic Shock
Adverse event was reported on Feb 08, 2010 by a Male patient taking Hexabrix (View Usage) (Dosage: 10, Ml Milliliter(s), 1, 1 Intra-arterial) was diagnosed with angiogram and. Location: JAPAN , 57 years of age, weighting 152.1 lb, After Hexabrix was administered, patient had the following side effects: anaphylactic shock. During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), ATARAX (View Atarax Review and Atarax Label ), KYTRIL (View Kytril Review and Kytril Label ).

6644127-2 | Anaphylactic Shock, Blood Pressure Systolic Decreased, Tachycardia, Troponin Increased
on Sep 03, 2009 Male patient from FRANCE , 53 years of age, was diagnosed with arteriogram coronary and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, blood pressure systolic decreased, tachycardia, troponin increased. Hexabrix dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with REOPRO: / ABCIXIMAB (Intravenous) (View Reopro: / Abciximab Review and Reopro: / Abciximab Label ).

6601904-1 | Anaphylactic Shock, Back Pain, Defaecation Urgency, Nausea, Oxygen Saturation Decreased
on Feb 08, 2010 Male patient from JAPAN , 57 years of age, was diagnosed with angiogram and was treated with Hexabrix (View Usage). Patient had the following side effects: anaphylactic shock, back pain (What is back pain?), defaecation urgency, nausea (What is nausea?), oxygen saturation decreased. Hexabrix dosage: 9 Ml Per Day, Intra-arterial.

6535738-3 | Circulatory Collapse, Conjunctival Hyperaemia
Patient was taking Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: circulatory collapse, conjunctival hyperaemia on Dec 29, 2009 from FRANCE Additional patient health information: Female patient , 62 years of age, was diagnosed with arteriogram coronary and. Hexabrix dosage: Intra-arterial. During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), DEPAKENE (View Depakene Review and Depakene Label ), TENORMIN (View Tenormin Review and Tenormin Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), SECTRAL (View Sectral Review and Sectral Label ), TRIATEC (View Triatec Review and Triatec Label ), TAHOR (View Tahor Review and Tahor Label ).

6454684-7 | Anaphylactic Shock
Adverse event was reported on Jun 17, 2008 by a Male patient taking Hexabrix (View Usage) (Dosage: 30 Ml Per Day, Intra-veinous) was diagnosed with arteriogram coronary and. Location: FRANCE , 61 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock.

6403806-2 | Blood Bilirubin Increased, Blood Glucose Increased, Blood Potassium Decreased, Bradycardia, Hypotension, Red Blood Cell Count Increased, Shock, Tachycardia
on Aug 05, 2009 Male patient from JAPAN , 50 years of age, was diagnosed with angiogram cerebral and was treated with Hexabrix (View Usage). Patient had the following side effects: blood bilirubin increased, blood glucose increased, blood potassium decreased, bradycardia, hypotension, red blood cell count increased, shock, tachycardia. Hexabrix dosage: Dosage: 40, Ml Millilitre(s), 1, 1, Total Intra-arterial. During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), NOVOLIN INSULIN HUMAN: / INSULIN (View Novolin Insulin Human: / Insulin Review and Novolin Insulin Human: / Insulin Label ), SOLITA T NO 3G: / SODIUM POTASSIUM CHLORIDE LACTATE (View Solita-t No 3g: / Sodium - Potassium - Chloride - Lactate Review and Solita-t No 3g: / Sodium - Potassium - Chloride - Lactate Label ), LACTEC: / SODIUM POTASSIUM CHLORIDE LACTATE (View Lactec: / Sodium - Potassium - Chloride - Lactate Review and Lactec: / Sodium - Potassium - Chloride - Lactate Label ), EKONAL: / NIZOFENONE FUMARATE (View Ekonal: / Nizofenone Fumarate Review and Ekonal: / Nizofenone Fumarate Label ), SOSEGON INJECTION: / PENTAZOCINE (View Sosegon Injection: / Pentazocine Review and Sosegon Injection: / Pentazocine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6398556-5 | Cognitive Disorder, Confusional State, Encephalopathy, Visual Impairment
on Sep 30, 2009 Male patient from FRANCE , 64 years of age, was diagnosed with arteriogram coronary and was treated with Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: cognitive disorder, confusional state, encephalopathy, visual impairment. Hexabrix dosage: Dosage: 158, Ml Millilitre(s), 1, 1, Total Intravenous. Patient was hospitalized.

6394405-X | Abdominal Pain, Malaise, Pelvic Pain, Vomiting
Patient was taking Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), malaise, pelvic pain (What is pelvic pain?), vomiting on Jan 22, 2009 from FRANCE Additional patient health information: Female patient , 35 years of age, was diagnosed with hysterosalpingogram and. Hexabrix dosage: Dosage: 13, Ml Millilitre(s), 1, 1, Total Intra-uterine. Patient was hospitalized.

6358966-9 | Erythema, Hyperhidrosis, Shock, Tachycardia
Adverse event was reported on Aug 05, 2009 by a Male patient taking Hexabrix (View Usage) (Dosage: 40, Ml Millilitre (s), 1, 1,) was diagnosed with angiogram cerebral and. Location: JAPAN , 50 years of age, Patient had the following side effects: erythema, hyperhidrosis, shock, tachycardia. During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), INSULIN (View Insulin Review and Insulin Label ), SOLITA T (View Solita-t Review and Solita-t Label ), POTASSIUM CHLORIDE (View Potassium - Chloride Review and Potassium - Chloride Label ), LACTEC (View Lactec Review and Lactec Label ), NIZOFENONE FUMARATE (View Nizofenone Fumarate Review and Nizofenone Fumarate Label ), PENTAZOCINE (View Pentazocine Review and Pentazocine Label ). Patient was hospitalized.

6336350-1 | Angioedema, Bronchospasm Paradoxical, Rash Rubelliform
on Apr 21, 2009 Male patient from SPAIN , 26 years of age, was diagnosed with angiogram and was treated with Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: angioedema, bronchospasm paradoxical, rash rubelliform. Hexabrix dosage: 200, Ml Millilitre(s), 1 , 1 Total Intra-arterial. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), SINTROM (View Sintrom Review and Sintrom Label ).

6329892-6 | Bronchospasm, Cyanosis, Dyspnoea, Hypotension, Nausea, Tachycardia
on Jul 30, 2009 Female patient from FRANCE , 49 years of age, was diagnosed with arteriogram coronary and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, cyanosis, dyspnoea, hypotension, nausea (What is nausea?), tachycardia. Hexabrix dosage: 28, Ml Millilitre(s), 1, 1, Intracoronary.

6310919-2 | Acute Pulmonary Oedema, Cardiac Arrest, Renal Failure Acute
Patient was taking Hexabrix (View Usage). Patient had the following side effects: acute pulmonary oedema, cardiac arrest (What is cardiac arrest?), renal failure acute on Aug 22, 2005 from FRANCE Additional patient health information: Male patient , 82 years of age, was diagnosed with arteriogram coronary and. Hexabrix dosage: Dosage: 600, Ml Millilitre(s), 1, 1, Total Intra-arterial. During the same period patient was treated with MUCOMYST (View Mucomyst Review and Mucomyst Label ). Patient was hospitalized.

6300501-5 | Angioedema, Oropharyngeal Discomfort
Adverse event was reported on Jul 28, 2009 by a Female patient taking Hexabrix (View Usage) (Dosage: Intravenous) was diagnosed with arteriogram coronary and. Location: FRANCE , 63 years of age, After Hexabrix was administered, patient had the following side effects: angioedema, oropharyngeal discomfort.

6292915-7 | Hypotension, Incontinence, Shock
on Jun 20, 2006 Male patient from JAPAN , 64 years of age, was diagnosed with catheterisation cardiac and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, incontinence, shock. Hexabrix dosage: .

6288602-1 | Anaphylactic Shock
on Jan 06, 2006 Male patient from FRANCE , 47 years of age, weighting 55.00 lb, was diagnosed with arteriogram coronary and was treated with Hexabrix (View Usage). Patient had the following side effects: anaphylactic shock. Hexabrix dosage: Intra-arterial. During the same period patient was treated with ISOSORBIDE DINITRATE (1, Mg Milligram(s), 1, 1, Total Intra-arterial) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), GELOFUSINE: / GELATIN (Intravenous) (View Gelofusine: / Gelatin Review and Gelofusine: / Gelatin Label ), HEPARIN CALCIUM (View Heparin Calcium Review and Heparin Calcium Label ), KARDEGIC: / LYSINE ACETYLSALICYLATE (View Kardegic: / Lysine Acetylsalicylate Review and Kardegic: / Lysine Acetylsalicylate Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), RENAGEL (View Renagel Review and Renagel Label ), CALCIDIA: / CALCIUM CARBONATE (View Calcidia: / Calcium Carbonate Review and Calcidia: / Calcium Carbonate Label ), PLAVIX (View Plavix Review and Plavix Label ).

6288528-3 | Anaphylactic Shock, Cardio-respiratory Arrest, Erythema, Feeling Hot, Loss Of Consciousness, Nausea
Patient was taking Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: anaphylactic shock, cardio-respiratory arrest, erythema, feeling hot, loss of consciousness, nausea (What is nausea?) on Dec 21, 2007 from FRANCE Additional patient health information: Male patient , 79 years of age, was diagnosed with arteriogram coronary and. Hexabrix dosage: 100, Ml Millilitre(s), 1, L, Total.

6288493-9 | Bronchospasm, Feeling Hot, Hypersensitivity, Sneezing, Swelling Face
Adverse event was reported on Oct 27, 2006 by a Male patient taking Hexabrix (View Usage) (Dosage: 150, Ml Millilitre(s), L, 1, Days Intra-arterial) was diagnosed with angiogram and. Location: FRANCE , 54 years of age, weighting 70.00 lb, Patient experienced the following unwanted or unexpected effects: bronchospasm, feeling hot, hypersensitivity, sneezing, swelling face.

6282578-9 | Blood Creatine Phosphokinase Increased, Dermatitis Bullous, Erythema, Pustular Psoriasis, Rash Vesicular
on Sep 18, 2007 Female patient from FRANCE , 69 years of age, was diagnosed with endoscopic retrograde cholangiopancreatography, cholangitis and was treated with Hexabrix (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, dermatitis bullous, erythema, pustular psoriasis, rash vesicular. Hexabrix dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), FLAGYL (View Flagyl Review and Flagyl Label ), AMIKIN (View Amikin Review and Amikin Label ). Patient was hospitalized.

6269538-9 | Anaphylactic Shock
on Jul 09, 2009 Female patient from FRANCE , 39 years of age, was diagnosed with arteriogram coronary and was treated with Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: anaphylactic shock. Hexabrix dosage: Intravenous. Patient was hospitalized.

6269537-7 | Abdominal Distension, Altered State Of Consciousness, Coma, Encephalitis, Formication, Hyperthermia, Myoclonus, Off Label Use
Patient was taking Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, altered state of consciousness, coma, encephalitis (What is encephalitis?), formication, hyperthermia, myoclonus, off label use on Feb 25, 2009 from FRANCE Additional patient health information: Female patient , 61 years of age, weighting 100.0 lb, was diagnosed with spinal myelogram and. Hexabrix dosage: Dosage: 12, Ml Millilitre (s), 1, 1, Total Intrathecal. Patient was hospitalized and became disabled.

6269185-9 | Off Label Use, Status Epilepticus
Adverse event was reported on Jul 20, 2007 by a Male patient taking Hexabrix (View Usage) (Dosage: ) was diagnosed with spinal myelogram and. Location: FRANCE , 48 years of age, Patient had the following side effects: off label use, status epilepticus.

6268088-3 | Arteriospasm Coronary, Bradycardia, Erythema, Rash, Shock
on Jan 25, 2007 Male patient from JAPAN , 50 years of age, was diagnosed with angiogram and was treated with Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: arteriospasm coronary, bradycardia, erythema, rash (What is rash?), shock. Hexabrix dosage: 25, Ml Millilitre(s), , , Intra-arterial. During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

6260487-9 | Abdominal Distension, Formication, Hyperthermia, Myoclonus, Nervous System Disorder, Off Label Use, Paraesthesia, Pruritus
on Feb 25, 2009 Female patient from FRANCE , 61 years of age, weighting 220.5 lb, was diagnosed with spinal myelogram and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, formication, hyperthermia, myoclonus, nervous system disorder, off label use, paraesthesia, pruritus. Hexabrix dosage: 12, Ml Millilitre (s), 1, 1, Total Intrathecal. Patient was hospitalized.

6254741-4 | Anaphylactic Shock, Pulmonary Arterial Pressure Increased, Respiratory Disorder, Urticaria
Patient was taking Hexabrix (View Usage). Patient had the following side effects: anaphylactic shock, pulmonary arterial pressure increased, respiratory disorder, urticaria on Jun 25, 2009 from FRANCE Additional patient health information: Female patient , 62 years of age, . Hexabrix dosage: . During the same period patient was treated with LIPIODOL: / ETHIODIZED OIL (View Lipiodol: / Ethiodized Oil Review and Lipiodol: / Ethiodized Oil Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), NIMBEX (View Nimbex Review and Nimbex Label ), ULTIVA (View Ultiva Review and Ultiva Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ). Patient was hospitalized.

6252217-1 | Abdominal Distension, Coma, Formication, Hyperthermia, Myoclonus, Neurological Symptom, Off Label Use, Paraesthesia, Pruritus
Adverse event was reported on Jun 25, 2009 by a Female patient taking Hexabrix (View Usage) (Dosage: 12, Ml Millilitre(s), 1, 1, Intrathecal) was diagnosed with spinal myelogram and. Location: FRANCE , 61 years of age, weighting 220.5 lb, After Hexabrix was administered, patient had the following side effects: abdominal distension, coma, formication, hyperthermia, myoclonus, neurological symptom, off label use, paraesthesia, pruritus. Patient was hospitalized.

6252209-2 | Formication, Off Label Use, Paraesthesia, Pruritus, Sensation Of Heaviness
on Feb 25, 2009 Male patient from FRANCE , 65 years of age, weighting 198.4 lb, was diagnosed with spinal myelogram and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: formication, off label use, paraesthesia, pruritus, sensation of heaviness. Hexabrix dosage: 12, Ml Millilitre (s) 1, 1, Total Intrathecal. Patient was hospitalized and became disabled.

6213496-X | Contrast Media Allergy, Oxygen Saturation Decreased
on May 28, 2009 Male patient from FRANCE , 69 years of age, was diagnosed with arteriogram and was treated with Hexabrix (View Usage). Patient had the following side effects: contrast media allergy, oxygen saturation decreased. Hexabrix dosage: . During the same period patient was treated with BRICANYL (View Bricanyl Review and Bricanyl Label ), TERBUTALINE SULFATE (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), ATROVENT (View Atrovent Review and Atrovent Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), TIOTROPIUM (View Tiotropium Review and Tiotropium Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ). Patient was hospitalized.

6182320-6 | Coma, Hyperthermia, Myoclonus, Neurological Symptom, Off Label Use, Pruritus, Somnolence, Status Epilepticus
Patient was taking Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: coma, hyperthermia, myoclonus, neurological symptom, off label use, pruritus, somnolence, status epilepticus on Feb 25, 2009 from FRANCE Additional patient health information: Female patient , 60 years of age, weighting 100.0 lb, was diagnosed with spinal myelogram and. Hexabrix dosage: Dosage: 12, Ml Millilitre (s), 1, 1, Total Intrathecal. Patient was hospitalized.

6182316-4 | Muscular Weakness, Myoclonus, Off Label Use, Paraesthesia, Pruritus, Sensation Of Heaviness
Adverse event was reported on Feb 25, 2009 by a Male patient taking Hexabrix (View Usage) (Dosage: Dosage: 12, Ml Millilitre(s), 1, 1, Total Intrathecal) was diagnosed with spinal myelogram and. Location: FRANCE , 58 years of age, weighting 90.00 lb, Patient experienced the following unwanted or unexpected effects: muscular weakness, myoclonus, off label use, paraesthesia, pruritus, sensation of heaviness. Patient was hospitalized.

6178471-2 | Angioedema, Bronchospasm Paradoxical, Rash Rubelliform
on Apr 21, 2009 Male patient from SPAIN , 26 years of age, was diagnosed with angiogram and was treated with Hexabrix (View Usage). Patient had the following side effects: angioedema, bronchospasm paradoxical, rash rubelliform. Hexabrix dosage: 200, Ml Millilitre(s), 1, 1, Total Intra-arterial. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), SINTROM (View Sintrom Review and Sintrom Label ).

6169980-0 | Angioedema, Bronchospasm Paradoxical, Rash Rubelliform
on Apr 21, 2009 Male patient from SPAIN , 26 years of age, was diagnosed with angiogram and was treated with Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: angioedema, bronchospasm paradoxical, rash rubelliform. Hexabrix dosage: 200, Ml Millilitre(s), Intra-arterial. During the same period patient was treated with RANITIDINE: ORAL / RANITIDINE (View Ranitidine: Oral / Ranitidine Review and Ranitidine: Oral / Ranitidine Label ), SINTROM: ORAL / ACENOCOUMAROL (View Sintrom: Oral / Acenocoumarol Review and Sintrom: Oral / Acenocoumarol Label ).

6164209-1 | Abdominal Pain, Anaphylactic Shock, Chills, Hyperthermia, Hypotension, Leukopenia, Lymphadenopathy, Malaise, Nausea
Patient was taking Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anaphylactic shock, chills, hyperthermia, hypotension, leukopenia, lymphadenopathy, malaise, nausea (What is nausea?) on Feb 19, 2009 from FRANCE Additional patient health information: Female patient , 34 years of age, was diagnosed with arthrogram and. Hexabrix dosage: . During the same period patient was treated with XYZALL (LEVOCETIRIZINE) (View Xyzall (levocetirizine) Review and Xyzall (levocetirizine) Label ). Patient was hospitalized.

6148838-7 | Anaphylactic Shock, Contrast Media Allergy, Hyperthermia, Laboratory Test Interference, Leukopenia, Lymphadenopathy, Neutropenia, Type Iv Hypersensitivity Reaction
Adverse event was reported on Feb 19, 2009 by a Female patient taking Hexabrix (View Usage) (Dosage: ) was diagnosed with arthrogram and. Location: FRANCE , 34 years of age, Patient had the following side effects: anaphylactic shock, contrast media allergy, hyperthermia, laboratory test interference, leukopenia, lymphadenopathy, neutropenia, type iv hypersensitivity reaction. During the same period patient was treated with XYZAL (View Xyzal Review and Xyzal Label ). Patient was hospitalized.

6138639-8 | Anaphylactic Shock, Cold Sweat, Cough, Dyspnoea, Feeling Abnormal, Hot Flush, Hypotension, Rash
on Jan 29, 2009 Male patient from JAPAN , 29 years of age, was diagnosed with angiogram and was treated with Hexabrix (View Usage). After Hexabrix was administered, patient had the following side effects: anaphylactic shock, cold sweat, cough, dyspnoea, feeling abnormal, hot flush, hypotension, rash (What is rash?). Hexabrix dosage: Dosage: 10, Ml Millilitre(s), 1, 1, Total; Intra-arterial Total. During the same period patient was treated with NALOXONE HCL (View Naloxone Hcl Review and Naloxone Hcl Label ).

6111446-8 | Coma, Hyperthermia, Myoclonus, Off Label Use, Pruritus, Somnolence, Status Epilepticus
on Feb 25, 2009 Female patient from FRANCE , 65 years of age, was diagnosed with spinal myelogram and was treated with Hexabrix (View Usage). Patient experienced the following unwanted or unexpected effects: coma, hyperthermia, myoclonus, off label use, pruritus, somnolence, status epilepticus. Hexabrix dosage: 10, Ml Millilitre(s), 1, 1, Intrathecal. Patient was hospitalized.

6106615-7 | Coma, Hyperthermia, Myoclonus, Off Label Use, Pruritus, Somnolence
Patient was taking Hexabrix (View Usage). Patient had the following side effects: coma, hyperthermia, myoclonus, off label use, pruritus, somnolence on Feb 25, 2009 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with spinal myelogram and. Hexabrix dosage: Dosage: 10, Ml Millilitre(s), 1, 1, Total. Patient was hospitalized.